Febbo William J's Form 4 filing
OptimizeRx Corp (OPRX) · filed Jan 20, 2022
- Accession no.
- 0001213900-22-002854
- Filed
- Jan 20, 2022
- Trade date
- Jan 18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $787.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo William JCIK 0001413987 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2022 | Common Stock | SSaleDisposed | −8,140 | $46.92 | −$381,928.8 | 470,864 | Direct | |
| Jan 18, 2022 | Common Stock | SSaleDisposed | −8,226 | $47.57 | −$391,310.82 | 462,638 | Direct | |
| Jan 18, 2022 | Common Stock | SSaleDisposed | −300 | $48.52 | −$14,556 | 462,338 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.